dapagliflozin - CISMeF

Preferred Label : dapagliflozin;

MeSH note : dapaglifozin is the (2S,3R,4R,5S,6R)-isomer; an SGLT2 inhibitor; structure in first source;

MeSH synonym : (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol;

MeSH hyponym : (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; BMS512148; BMS-512148; Forxiga;

MeSH Related Number : dapagliflozin; 1ULL0QJ8UC;

Related CAS MeSH : 1ULL0QJ8UC (dapagliflozin);

Is substance : O;

UNII : 1ULL0QJ8UC;

Details

Origin ID

C529054;

UMLS CUI

C2353951;

ATC code(s)
- dapagliflozin [ATC Code]
- gemigliptin and dapagliflozin [ATC Code]
- metformin and dapagliflozin [ATC Code]
- metformin, saxagliptin and dapagliflozin [ATC Code]
- saxagliptin and dapagliflozin [ATC Code]
- sitagliptin and dapagliflozin [ATC Code]
Currated CISMeF NLP mapping
- Dapagliflozin [SMS substance]
- Dapagliflozin [ICD-11 Extension code]
- Dapagliflozin [NCIt concept]
- Dapagliflozin (substance) [SNOMED CT concept]
MeSH indexing information
- Sodium-Glucose transport proteins [MeSH Descriptor]
MeSH term(s) associated for indexing
- benzhydryl compounds [MeSH Descriptor]
- glucosides [MeSH Descriptor]
Pharmacological action(s)
- Sodium-Glucose Transporter 2 Inhibitors [MeSH Descriptor]
Record concept(s)
- 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol [MeSH concept]
- BMS 512148 [MeSH concept]
- Farxiga [MeSH concept]
- dapagliflozin [MeSH concept]
See also inter- (CISMeF)
- Product containing dapagliflozin (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dapagliflozin [NCIt concept]
- Dapagliflozin (substance) [SNOMED CT concept]
- Product containing dapagliflozin (medicinal product) [SNOMED CT concept]
- dapagliflozin [ATC Code]
Validated automatic mappings to BTNT
- dapagliflozin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients